Ascelia Pharma AB (publ) Overview
Get informed when a big investor buys or sells
+ Follow-1.16
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, ACE.ST shows a P/E ratio of -1.16. That is below the Healthcare sector average of 22.57. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 22.57. Ascelia Pharma AB (publ) is at -1.16, which is lower that average. That is roughly 105.1% below the sector mean. Use the comparison chart on this page to see how ACE.ST stacks up against individual peers as well.
Investors watch ACE.ST's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Ascelia Pharma AB (publ)'s latest reading is -1.16. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Ascelia Pharma AB (publ)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently -1.16) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 22.57, while ACE.ST is at -1.16. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
